A health care startup founded by researchers from Caltech hopes to make heart failure diagnosis more straightforward and accessible, potentially changing the course of the disease for many people.
The company, Ventric Health, announced this week that it has received clearance from the Food and Drug Administration (FDA) to sell Vivio®, a device that can noninvasively detect signs of heart failure.
The device and the company are an outgrowth of research conducted at Caltech by Mory Gharib (PhD '83), Ventric Health co-founder and the Hans W. Liepmann Professor of Aeronautics and Medical Engineering. In 2017, Gharib announced that he and researchers in his lab had developed a smartphone app that could assess heart health using the phone's camera. [Caltech story]